Data Mining of Molecular Simulations Suggest Key Amino Acid Residues for Aggregation, Signaling and Drug Action
Open Access
- 19 October 2021
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 11 (10) , 1541
Abstract
Alzheimer’s disease, the most common form of dementia, currently has no cure. There are only temporary treatments that reduce symptoms and the progression of the disease. Alzheimer’s disease is characterized by the prevalence of plaques of aggregated amyloid β (Aβ) peptide. Recent treatments to prevent plaque formation have provided little to relieve disease symptoms. Although there have been numerous molecular simulation studies on the mechanisms of Aβ aggregation, the signaling role has been less studied. In this study, a total of over 38,000 simulated structures, generated from molecular dynamics (MD) simulations, exploring different conformations of the Aβ42 mutants and wild-type peptides were used to examine the relationship between Aβ torsion angles and disease measures. Unique methods characterized the data set and pinpointed residues that were associated in aggregation and others associated with signaling. Machine learning techniques were applied to characterize the molecular simulation data and classify how much each residue influenced the predicted variant of Alzheimer’s Disease. Orange3 data mining software provided the ability to use these techniques to generate tables and rank the data. The test and score module coupled with the confusion matrix module analyzed data with calculations of specificity and sensitivity. These methods evaluating frequency and rank allowed us to analyze and predict important residues associated with different phenotypic measures. This research has the potential to help understand which specific residues of Aβ should be targeted for drug development.Keywords
This publication has 26 references indexed in Scilit:
- Familial Alzheimer’s Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β PeptideJournal of Biological Chemistry, 2017
- Aβ Monomers Transiently Sample Oligomer and Fibril-Like Configurations: Ensemble Characterization Using a Combined MD/NMR ApproachJournal of Molecular Biology, 2013
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With GantenerumabArchives of Neurology, 2012
- Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer DiseaseJournal of Biological Chemistry, 2012
- Atomic-Level Characterization of the Ensemble of the Aβ(1–42) Monomer in Water Using Unbiased Molecular Dynamics Simulations and Spectral AlgorithmsJournal of Molecular Biology, 2011
- Mutations Enhance the Aggregation Propensity of the Alzheimer’s Aβ PeptideJournal of Molecular Biology, 2008
- The Alzheimer’s Peptides Aβ40 and 42 Adopt Distinct Conformations in Water: A Combined MD / NMR StudyJournal of Molecular Biology, 2007
- Residues 17–20 and 30–35 of beta‐amyloid play critical roles in aggregationJournal of Neuroscience Research, 2003
- Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMRBiochemistry, 2000
- Quantitative J correlation: a new approach for measuring homonuclear three-bond J(HNH.alpha.) coupling constants in 15N-enriched proteinsJournal of the American Chemical Society, 1993